[HTML][HTML] Erlotinib-loaded dendrimer nanocomposites as a targeted lung cancer chemotherapy
Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy
WK Fatani, FS Aleanizy, FY Alqahtani, MM Alanazi… - …, 2023 - search.proquest.com
Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
[HTML][HTML] Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy
WK Fatani, FS Aleanizy, FY Alqahtani, MM Alanazi… - Molecules, 2023 - ncbi.nlm.nih.gov
Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy.
WK Fatani, FS Aleanizy, FY Alqahtani… - Molecules (Basel …, 2023 - europepmc.org
Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy.
WK Fatani, FS Aleanizy, FY Alqahtani… - …, 2023 - search.ebscohost.com
Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy
WK Fatani, FS Aleanizy… - Molecules (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy.
WK Fatani, FS Aleanizy, FY Alqahtani… - Molecules (Basel …, 2023 - europepmc.org
Lung cancer is the main cause of cancer-related mortality globally. Erlotinib is a tyrosine
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …
kinase inhibitor, affecting both cancerous cell proliferation and survival. The emergence of …